产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 16123042 | LY-3177833 | 1627696-51-8 | 98% |  |
| LY-3177833 is a potent and selective inhibitor of CDC7 (Cell Division Cycle 7-related | ||||
| 16123041 | LY3009120 | 1454682-72-4 | 98% | |
| LY3009120, also known as DP-4978, is potent and selective pan-RAF inhibitor with pote | ||||
| 16123040 | LY2334737 | 892128-60-8 | 98% | |
| LY2334737 is an orally available valproic acid ester of gemcitabine, a broad-spectrum | ||||
| 16123039 | LY2109761 | 700874-71-1 | 98% |  |
| LY2109761 is a novel transforming growth factor beta receptor type I and type II dual | ||||
| 16123038 | Luliconazole | 187164-19-8 | 98% |  |
| Luliconazole is an azole antifungal drug. As a 1% topical cream, luliconazole is indi | ||||
| 16123037 | Lubiprostone | 333963-40-9 | 98% |  |
| Lubiprostone, also known as RU-0211, is a medication used in the management of chroni | ||||
| 16123036 | LOXO-101 (ARRY-470) | 1223403-58-4 | 98% | -cas-1223403-58-4.png) |
| Larotrectinib, also known as ARRY-470 and LOXO-101, is an orally bioavailable, potent | ||||
| 16123035 | Lomitapide free base | 182431-12-5 | 98% |  |
| Lomitapide is a MTP inhibitor. Lomitapid is a novel agent for the treatment of homozy | ||||
| 16123034 | Lometrexol disodium | 106400-81-1 | 98% |  |
| Lometrexol is a folate analog antimetabolite with antineoplastic activity. As the 6R | ||||
| 16123033 | LGK974 (WNT974) | 1243244-14-5 | 98% | -cas-1243244-14-5.png) |
| LGK974, aslo known as is a selective and orally bioavailable Porcupine (PORCN) inhibi | ||||
| 16123031 | Levobupivacaine free base | 27262-47-1 | 98% |  |
| Levobupivacaine is a local anaesthetic drug belonging to the amino amide group. It is | ||||
| 16122828 | L67 | 325970-71-6 | 98% | |
| L67 is a DNA Ligase Inhibitor. L67 inhibited DNA ligases I and III. L67 is a simple c | ||||
| 161227107 | Leukadherin-1 | 344897-95-6 | 98% | |
| Leukadherin-1 (LA1) is a small molecule agonist that enhances CD11b/CD18-dependent ce | ||||
| 16122765 | Ledipasvir (GS5885) | 1256388-51-8 | 98% | -cas-1256388-51-8.png) |
| Ledipasvir (GS5885) is a HCV NS5A polymerase inhibitor, used for the treatment of hep | ||||
| 16122739 | LLY-507 | 1793053-37-8 | 98% |  |
| LLY-507 is a cell-active, potent, and selective inhibitor of protein-lysine Methyltra | ||||
| 16122736 | Lirametostat ( CPI-1205 ) | 1621862-70-1 | ≧98.0% | _1621862-70-1.png) |
| Lirametostat ( CPI-1205 ) 是一种有效的、选择性的、辅助因子竞争性的 | ||||
| 16122732 | L755507 | 159182-43-1 | 98% |  |
| L-755,507 is characterized as a potent and selective 3 adrenergic receptor partial ag | ||||
| 16122722 | LY333531 | 169939-93-9 | 98% |  |
| LY333531 is a -specific protein kinase C inhibitor. It competitively and reversibly i | ||||
| 6111410 | Lenalidomide hydrochloride | 1243329-97-6 | 98% | |
| Lenalidomide (Revlimid, CC-5013) is a TNF- secretion inhibitor with IC50 of 13 nM | ||||
| 6111409 | Lenalidomide hemihydrate | 847871-99-2 | 98% | |
| Lenalidomide (Revlimid, CC-5013) is a TNF- secretion inhibitor with IC50 of 13 nM.Len | ||||
| 61123 | LOXO-101 | 1223405-08-0 | 98% | |
| LOXO-101 is an oral potent and selective ATP-competitive inhibitor of tropomyosin rec | ||||
| 61120 | LPA2 antagonist 1 | 1017606-66-4 | 98% | |
| LPA2 antagonist 1 is a selective inhibitor of LPA2 activity in with IC50 17 nM in vit | ||||
| 6111018 | Liproxstatin-1 | 950455-15-9 | 98% |  |
| Liproxstatin-1 | ||||
| 6111006 | Lasmiditan | 439239-90-4 | 98% |  |
| Lasmiditan (COL-144; LY573144) is a high-affinity, highly selective 5-HT1F receptor a | ||||
| 6111005 | Lasmiditan hydrochloride | 613677-28-4 | 98% |  |
| Lasmiditan (COL-144; LY573144) is a high-affinity, highly selective 5-HT1F receptor a | ||||
| 611944 | Litronesib | 910634-41-2 | 98% |  |
| Litronesib is a selective, allosteric inhibitor of Eg5, which may result in mitotic d | ||||
| 611819 | LY 303511 hydrochloride | 2070014-90-1 | 98% |  |
| LY303511 Hcl, an inactive analogue of LY294002, is a mTOR inhibitor that did not inhi | ||||
| 611818 | LY 303511 | 154447-38-8 | 98% |  |
| LY303511, an inactive analogue of LY294002, is a mTOR inhibitor that did not inhibit | ||||
| 611808 | LY3023414 | 1386874-06-1 | 98% |  |
| LY3023414 is an oral ATP competitive inhibitor of the class I PI3K isoforms, mTOR and | ||||
| 16071412 | Lifitegrast | 1025967-78-5 | 98% by HPLC |  |
| Lifitegrast, also known as SAR-1118, is an LFA-1 antagonist intended for the treatmen | ||||